KS900: A hypoxia-directed, reductively activated...

Biochemical Pharmacology 2011 Vol. 81; Iss. 10

KS900: A hypoxia-directed, reductively activated methylating antitumor prodrug that selectively ablates O6-alkylguanine-DNA alkyltransferase in neoplastic cells

Raymond P. Baumann, Kimiko Ishiguro, Philip G. Penketh, Krishnamurthy Shyam, Rui Zhu, Alan C. Sartorelli
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
81
Year:
2011
Language:
english
Pages:
10
DOI:
10.1016/j.bcp.2011.02.019
File:
PDF, 1.09 MB
english, 2011
Conversion to is in progress
Conversion to is failed